Esmolol Hydrochloride Injection, Solution
Product Images NDC 0404-9858

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esmolol Hydrochloride (NDC 0404-9858). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Not available. The text appears to be a chemical formula, but there are missing characters and symbols, making it unreadable.*

FDA Label Image

Image1.jpg (Image1)

FDA Label Image

Image2.jpg (Image2)

This text provides dosage recommendations for a medication. It suggests an optional loading dose of 500 mcg per kg over 1 minute, followed by a maintenance dose of 50-200 mcg per kg per minute for up to 4 minutes, depending on the situation. The medication and its use are not specified.*

FDA Label Image

Image3.jpg (Image3)

This is a table presenting information about Esmolol Hydrochloride Injection, including its product name, total dose, concentration, and packaging. The product name is Esmolol Hydrochloride Injection, and each vial contains a total dose of 100 mg/10 mL with a concentration of 10 mg/mL. The packaging of this injection is a 10 mL vial.*

FDA Label Image

Image4.jpg (Image4)

This is a description of the clinical trial adverse reactions of a medication. The table shows the frequency of adverse reactions that occurred during the trial. The reactions with a frequency of over 3% are presented. The adverse reactions mostly affected vascular disorders, such as hypotension, both asymptomatic and symptomatic. General disorders of infusion site reactions and administration site conditions were observed in 8%, while gastrointestinal disorders of nausea accounted for 7% of the cases. Nervous system disorders such as dizziness and somnolence represented 3% of the reactions.*

FDA Label Image

Image5.jpg (Image5)

Table 4 is showing the formulation of Esmolol Hydrochloride Injection, which contains Esmolol Hydrochloride USP (10 mg/mL) and Water for Injection USP. It also includes Sodium Acetate Trihydrate USP (2.8 mg/mL), Glacial Acetic Acid USP (0.546 mg/mL), Sodium Hydroxide (0.5. to adjust pH to 4.5-5.5), Hydrachloric Acid (0. to adjust pH to 4.5-5.5), and Quantity sufficient (0.).*

FDA Label Image

Image6.jpg (Image6)

This is a pharmaceutical product available in a carton of 25 single-dose vials. Each vial contains 10mL of solution with a concentration of 10mg/mL, totaling 100mg per vial. The NDC number is 55150-194-10.*

FDA Label Image

Label1.jpg (Label1)

Esmolol Hydrochloride is an intravenous medication with a concentration of 100mg per 10ml. It is recommended to store it at a temperature of 20 to 26°C and discard any unused portion. It is not meant for children and contains no natural ingredients but may include preservatives. Additional information includes the item number 2480896 and the lot number XXXKXXXXX with manufacturer's insertion. The packaging was done by GTIN01000000000000CK Vienry Schein, Inc and the medication was filled in Bastian, VA 24314.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.